Parveen Kundu

Parveen Kundu

Active Director Designated Partner DIN 07944292
DIN 07944292 First appointment Oct 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Oct 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Parveen Kundu

Data last updated:

Parveen Kundu is a Designated Partner at Rohtak Nuclear Medcare Llp (since 2017), Director at Nuctherain Private Limited (since 2025) and Partner at Mitti Theranostics Llp (since 2022). The companies operate in Healthcare. The largest current company by reported revenue is Rohtak Nuclear Medcare Llp at ₹6.35 Cr (FY 2025). Earlier, Parveen Kundu was a Director at Nuclear Medsystems India Private Limited (2021–2022) and Designated Partner at Nuclear Medsystems India Llp (from 2017).

DIN 07944292
Primary Designation Designated Partner
Industry Healthcare
First Appointment 16 Oct 2017
Oldest Company Age 9 yrs
Largest company Rohtak Nuclear Medcare Llp Β· ₹6.35 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Oct 20172017₹6.35 Cr (FY 2025)Active
Nuctherain Private Limited U72100HR2025PTC136634
Director18 Sep 20252025Active
Partner19 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jun 20212021₹14.46 Cr (FY 2024)Active
Designated Partner11 Dec 20172017Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Parveen Kundu

NameDINCompanyDesignation
Manju09661488Rohtak Nuclear Medcare LlpDesignated Partner
Sajni Devi09661739Rohtak Nuclear Medcare LlpDesignated Partner
Shubham Vashistha11305684Nuctherain Private LimitedDirector
Amburanjan Santra10034462Mitti Theranostics LlpDesignated Partner
Papia Santra10034463Mitti Theranostics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mitti Theranostics Llp
Nuclear Medsystems India Llp
Rohtak Nuclear Medcare Llp
Nuctherain Private Limited
Premium access

Shareholding and investment profile for Parveen Kundu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parveen Kundu

Parveen Kundu currently holds 3 directorships: Rohtak Nuclear Medcare Llp (Designated Partner, since 16 Oct 2017, revenue β‚Ή6.35 Cr (FY 2025)); Nuctherain Private Limited (Director, since 18 Sep 2025); Mitti Theranostics Llp (Partner, since 19 Dec 2022).

Parveen Kundu was first appointed on 16 Oct 2017 as Designated Partner at Rohtak Nuclear Medcare Llp. The most recent appointment on record is 18 Sep 2025 at Nuctherain Private Limited.

Parveen Kundu held 2 earlier board appointments: Nuclear Medsystems India Private Limited (Director, 24 Jun 2021 to 01 Sep 2022); Nuclear Medsystems India Llp (Designated Partner, from 11 Dec 2017).

The current boards of Parveen Kundu's companies include Manju (Rohtak Nuclear Medcare Llp), Sajni Devi (Rohtak Nuclear Medcare Llp), Shubham Vashistha (Nuctherain Private Limited), Amburanjan Santra (Mitti Theranostics Llp), Papia Santra (Mitti Theranostics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available